Specialty Drugs Now Cost More Than the Median Household Income

November 20, 2015

(Washington Post) – The average annual retail cost of specialty drugs used to treat complex diseases such as cancer, rheumatoid arthritis and multiple sclerosis now exceeds the median U.S. household income,¬†according to a report to be published Friday. The study of 115 specialty drugs found that a year’s worth of prescriptions for a single drug retailed¬†at $53,384 per year, on average, in 2013 — more than the median U.S. household income, double the median income of Medicare beneficiaries, and more than three times as much as the average Social Security benefit in the same year.

Recommended Reading